Haleon days: GSK explains demerger decision
New company Haleon will become standalone venture as GSK’s strategy for the future unfolds
Read More
Author: John Pinching
Victory Road: NHS successful in 11 year claim against Servier
The European Commission finds that Servier committed a breach of competition over blood pressure drug
Read More
PANORAMIC view of World’s largest COVID study
Study involving 10,000 patients will investigate a range of potentially ground-breaking oral antivirals
Read More
Data day: Trial results deliver hope for prostate cancer patients
New combination treatment can significantly reduce the risk of death among prostate cancer patients
Read More
All trades: Syncona announces sale of portfolio company to Novartis
Company focused on founding and building global leaders in life science sold to Novartis
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
